Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
2.985
-0.055 (-1.81%)
Aug 14, 2026, 11:14 AM EDT - Market open
Apyx Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 58.42 | 52.84 | 48.1 | 52.35 | 44.51 | 48.52 | |
Revenue Growth | 25.59% | 9.86% | -8.11% | 17.61% | -8.26% | 75.08% |
Cost of Revenue | 21.32 | 19.8 | 18.74 | 18.59 | 15.38 | 14.92 |
Gross Profit | 37.09 | 33.04 | 29.36 | 33.76 | 29.13 | 33.6 |
Selling, General & Admin | 37.33 | 36.12 | 43.13 | 48.27 | 48.15 | 43.73 |
Research & Development | 3.3 | 3.37 | 5.08 | 5.44 | 4.54 | 4.32 |
Other Operating Expenses | - | - | - | -2.69 | - | - |
Total Operating Expenses | 40.63 | 39.49 | 48.21 | 51.02 | 52.69 | 48.05 |
Operating Income | -3.54 | -6.45 | -18.85 | -17.26 | -23.56 | -14.45 |
Interest Income | 1.02 | 1.11 | 1.61 | 0.92 | 0.16 | 0.01 |
Interest Expense | -5.58 | -5.59 | -5.91 | -2.48 | -0.02 | -0.01 |
Other Non-Operating Income (Expense) | 0.13 | 0.09 | -0.16 | -2.47 | 0.51 | -0.37 |
Total Non-Operating Income (Expense) | -4.43 | -4.39 | -4.46 | -4.02 | 0.65 | -0.37 |
Pretax Income | -7.97 | -10.84 | -23.31 | -21.28 | -22.91 | -14.82 |
Provision for Income Taxes | 0.44 | 0.27 | 0.25 | -2.43 | 0.37 | 0.38 |
Net Income | -8.41 | -11.11 | -23.56 | -18.85 | -23.28 | -15.2 |
Minority Interest in Earnings | -0.17 | - | - | - | - | - |
Net Income to Common | -8.63 | -11.21 | -23.46 | -18.71 | -23.18 | -15.17 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 43 | 41 | 36 | 35 | 35 | 34 |
Shares Outstanding (Diluted) | 43 | 41 | 36 | 35 | 35 | 34 |
Shares Change | 10.49% | 15.62% | 2.66% | 0.31% | 0.54% | 0.35% |
EPS (Basic) | -0.20 | -0.27 | -0.66 | -0.54 | -0.67 | -0.44 |
EPS (Diluted) | -0.20 | -0.27 | -0.66 | -0.54 | -0.67 | -0.44 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -11.05 | -9.12 | -18.77 | -5.78 | -21.29 | -11.17 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.26 | -0.22 | -0.53 | -0.17 | -0.62 | -0.33 |
Gross Margin | 63.50% | 62.53% | 61.04% | 64.49% | 65.45% | 69.26% |
Operating Margin | -6.06% | -12.20% | -39.18% | -32.97% | -52.94% | -29.78% |
Profit Margin | -14.40% | -21.01% | -48.98% | -36.01% | -52.30% | -31.33% |
FCF Margin | -18.91% | -17.25% | -39.02% | -11.05% | -47.83% | -23.03% |
EBITDA | -2.76 | -5.79 | -18.25 | -16.57 | -22.67 | -13.55 |
EBITDA Margin | -4.72% | -10.96% | -37.93% | -31.65% | -50.94% | -27.92% |
EBIT | -3.54 | -6.45 | -18.85 | -17.26 | -23.56 | -14.45 |
EBIT Margin | -6.06% | -12.20% | -39.18% | -32.97% | -52.94% | -29.78% |
Effective Tax Rate | -5.51% | -2.49% | -1.08% | 11.43% | -1.60% | -2.56% |